Candel’s viral therapy shows promising survival in small pancreatic cancer study

To Candel Therapeutics CEO Paul Peter Tak, the biotech’s viral immunotherapy has passed the “bloody obvious test” in pancreatic cancer, and it’s preparing to start …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Understaffed RCM Payment Teams Need a New Way Forward

Shantanu Gangal, CEO, Prodigal Last year, only 8% of healthcare executives said their RCM or billing departments were adequately staffed, and a stunning 48% said

November 2, 2023

Pfizer, BioNTech deny Arbutus and Genevant’s Covid vaccine patent infringement claims

Pfizer and BioNTech responded to a patent infringement suit filed by Arbutus Biopharma and Genevant, denying the accusation that their Covid-19 vaccine infringed on patents

July 14, 2023

UCLA Health receives $1.72 million grant to advance brain tumor research and training

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have been awarded a $1.72 million grant from the National Institutes of Health to support the

February 4, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.